Product Datasheet  
AML1 (Phospho-Ser303) Antibody  
Catalog Number: 12003  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species：  
  • Rabbit
  • Amount：  
  • 100μgμg
  • Swiss-Prot No.：  
  • Swiss-Prot#: Q01196;
    NCBI Gene#: 861;
    NCBI Protein#: NP_001001890.1
  • Form of Antibody：  
  • Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Storage：  
  • Store at -20˚C/1 year
  • Immunogen：  
  • Peptide sequence around phosphorylation site of serine 303 (T-A-F(p)-S-D) derived from Human AML1.
  • reactivity：  
  • Hu Ms Rt
  • appl_detail：  
  • Predicted MW: 50kd
    Western blotting: 1:500~1:1000
  • other_names：  
  • CBFA2, EVI-1, AMLCR1, PEBP2aB, AML1-EVI-1
  • Purification：  
  • Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
  • Specificity：  
  • The antibody detects endogenous level of AML1 only when phosphorylated at Serine 303.
  • Applications：  
  • WB
  • Background：  
  • CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.



 
© Signalway Biotechnology All Rights Reserved.